Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Davis

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Investigative Ophthalmology & Visual Science|November 1, 1989
A donor-age-dependent change in the activity of alpha-mannosidase in human cultured RPE cellsR E Wyszynski, W E Bruner, D B Cano, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
Pharmacokinetics and pharmacodynamics of a humanized monoclonal antibody to factor IX in cynomolgus monkeysL J Benincosa, F S Chow, L P Tobia, et al.
The Journal of Experimental Medicine|June 1, 1989
The role of polymorphic I-Ak beta chain residues in presentation of a peptide from myelin basic proteinC B Davis, J M Buerstedde, D J McKean, et al.
Nucleic Acids Research|July 25, 1986
The influence of ionic strength on the binding of a water soluble porphyrin to nucleic acidsR F Pasternack, P Garrity, B Ehrlich, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 24, 1999
Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonal antibody directed to human interleukin-5, in monkeysP Zia-Amirhosseini, E Minthorn, L J Benincosa, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 1, 1995
Renal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley ratsT W Hepburn, C B Davis, J J Urbanski, et al.
Clinical Pharmacology and Therapeutics|October 8, 1999
A population pharmacokinetic-pharmacodynamic analysis of single doses of clenoliximab in patients with rheumatoid arthritisD R Mould, C B Davis, E A Minthorn, et al.
Nature|January 17, 1991
Participation of CD4 coreceptor molecules in T-cell repertoire selectionH S Teh, A M Garvin, K A Forbush, et al.
The Journal of Infectious Diseases|September 1, 1996
The pharmacokinetics, antigenicity, and fusion-inhibition activity of RSHZ19, a humanized monoclonal antibody to respiratory syncytial virus, in healthy volunteersD E Everitt, C B Davis, K Thompson, et al.
Advances in Experimental Medicine and Biology|January 1, 1992
Differential involvement of protein tyrosine kinases p56lck and p59fyn in T cell developmentN S van Oers, A M Garvin, M P Cooke, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Investigative Ophthalmology & Visual Science|November 1, 1989
A donor-age-dependent change in the activity of alpha-mannosidase in human cultured RPE cellsR E Wyszynski, W E Bruner, D B Cano, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
Pharmacokinetics and pharmacodynamics of a humanized monoclonal antibody to factor IX in cynomolgus monkeysL J Benincosa, F S Chow, L P Tobia, et al.
The Journal of Experimental Medicine|June 1, 1989
The role of polymorphic I-Ak beta chain residues in presentation of a peptide from myelin basic proteinC B Davis, J M Buerstedde, D J McKean, et al.
Nucleic Acids Research|July 25, 1986
The influence of ionic strength on the binding of a water soluble porphyrin to nucleic acidsR F Pasternack, P Garrity, B Ehrlich, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 24, 1999
Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonal antibody directed to human interleukin-5, in monkeysP Zia-Amirhosseini, E Minthorn, L J Benincosa, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 1, 1995
Renal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley ratsT W Hepburn, C B Davis, J J Urbanski, et al.
Clinical Pharmacology and Therapeutics|October 8, 1999
A population pharmacokinetic-pharmacodynamic analysis of single doses of clenoliximab in patients with rheumatoid arthritisD R Mould, C B Davis, E A Minthorn, et al.
Nature|January 17, 1991
Participation of CD4 coreceptor molecules in T-cell repertoire selectionH S Teh, A M Garvin, K A Forbush, et al.
The Journal of Infectious Diseases|September 1, 1996
The pharmacokinetics, antigenicity, and fusion-inhibition activity of RSHZ19, a humanized monoclonal antibody to respiratory syncytial virus, in healthy volunteersD E Everitt, C B Davis, K Thompson, et al.
Advances in Experimental Medicine and Biology|January 1, 1992
Differential involvement of protein tyrosine kinases p56lck and p59fyn in T cell developmentN S van Oers, A M Garvin, M P Cooke, et al.
Pageof 6